Literature DB >> 21413900

Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels.

Simone Wirz1, Maren Dietrich, Thomas C Flanagan, Gudrun Bokermann, Wolfgang Wagner, Thomas Schmitz-Rode, Stefan Jockenhoevel.   

Abstract

Fibrin-based scaffolds are widely used in tissue engineering. We postulated that the use of platelet-rich plasma (PRP) in contrast to platelet-poor plasma and pure fibrinogen as the basic material leads to an increased release of autologous platelet-derived growth factor (PDGF)-AB, which may have a consequent positive effect on tissue development. Therefore, we evaluated the release of PDGF-AB during the production process and the course of PDGF release during cultivation of plasma gels with and w/o platelets. The influence of PDGF-AB on the proliferation rate of human umbilical cord artery smooth muscle cells (HUASMCs) was studied using XTT assay. The synthesis of extracellular matrix by HUASMCs in plasma- and fibrin gels was measured using hydroxyproline assay. The use of PRP led to an increase in autologous PDGF-AB release. Further, the platelet-containing plasma gels showed a prolonged release of growth factor during cultivation. Both PRP and platelet-poor plasma gels had a positive effect on the production of collagen. However, PDGF-AB as a supplement in medium and in pure fibrin gel had neither an effect on cell proliferation nor on the collagen synthesis rate. This observation may be due to an absence of PDGF receptors in HUASMCs as determined by flow cytometry. In conclusion, although the prolonged autologous production of PDGF-AB in PRP gels is possible, the enhanced tissue development by HUASMCs within such gels is not PDGF related.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21413900     DOI: 10.1089/ten.TEA.2010.0610

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  6 in total

1.  Laser printing of three-dimensional multicellular arrays for studies of cell-cell and cell-environment interactions.

Authors:  Martin Gruene; Michael Pflaum; Christian Hess; Stefanos Diamantouros; Sabrina Schlie; Andrea Deiwick; Lothar Koch; Mathias Wilhelmi; Stefan Jockenhoevel; Axel Haverich; Boris Chichkov
Journal:  Tissue Eng Part C Methods       Date:  2011-06-29       Impact factor: 3.056

Review 2.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

3.  Root-end surgery with leucocyte- and platelet-rich fibrin and an occlusive membrane: a randomized controlled clinical trial on patients' quality of life.

Authors:  Nastaran Meschi; Steffen Fieuws; Anke Vanhoenacker; Olaf Strijbos; Dominique Van der Veken; Constantinus Politis; Paul Lambrechts
Journal:  Clin Oral Investig       Date:  2018-03-09       Impact factor: 3.573

4.  Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells.

Authors:  Michael Lohmann; Gudrun Walenda; Hatim Hemeda; Sylvia Joussen; Wolf Drescher; Stefan Jockenhoevel; Gabriele Hutschenreuter; Martin Zenke; Wolfgang Wagner
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Lyophilised Platelet-Rich Fibrin: Physical and Biological Characterisation.

Authors:  Nurul Aida Ngah; George J Dias; Darryl C Tong; Siti Noor Fazliah Mohd Noor; Jithendra Ratnayake; Paul R Cooper; Haizal Mohd Hussaini
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

6.  Two Hits for Bone Regeneration in Aged Patients: Vertebral Bone Marrow Clot as a Biological Scaffold and Powerful Source of Mesenchymal Stem Cells.

Authors:  Francesca Salamanna; Deyanira Contartese; Veronica Borsari; Stefania Pagani; Giovanni Barbanti Brodano; Cristiana Griffoni; Alessandro Ricci; Alessandro Gasbarrini; Milena Fini
Journal:  Front Bioeng Biotechnol       Date:  2022-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.